168 related articles for article (PubMed ID: 17848574)
1. MDM2 chaperones the p53 tumor suppressor.
Wawrzynow B; Zylicz A; Wallace M; Hupp T; Zylicz M
J Biol Chem; 2007 Nov; 282(45):32603-12. PubMed ID: 17848574
[TBL] [Abstract][Full Text] [Related]
2. Functional inactivation of endogenous MDM2 and CHIP by HSP90 causes aberrant stabilization of mutant p53 in human cancer cells.
Li D; Marchenko ND; Schulz R; Fischer V; Velasco-Hernandez T; Talos F; Moll UM
Mol Cancer Res; 2011 May; 9(5):577-88. PubMed ID: 21478269
[TBL] [Abstract][Full Text] [Related]
3. ATP stimulates MDM2-mediated inhibition of the DNA-binding function of E2F1.
Stevens C; Pettersson S; Wawrzynow B; Wallace M; Ball K; Zylicz A; Hupp TR
FEBS J; 2008 Oct; 275(19):4875-86. PubMed ID: 18754770
[TBL] [Abstract][Full Text] [Related]
4. ATP binding to Hsp90 is sufficient for effective chaperoning of p53 protein.
Walerych D; Gutkowska M; Klejman MP; Wawrzynow B; Tracz Z; Wiech M; Zylicz M; Zylicz A
J Biol Chem; 2010 Oct; 285(42):32020-8. PubMed ID: 20688913
[TBL] [Abstract][Full Text] [Related]
5. MDM2 binding induces a conformational change in p53 that is opposed by heat-shock protein 90 and precedes p53 proteasomal degradation.
Sasaki M; Nie L; Maki CG
J Biol Chem; 2007 May; 282(19):14626-34. PubMed ID: 17363365
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 Sequestration of the MDM2 Acidic Domain Inhibits E3 Ligase Activity.
Yang L; Song T; Cheng Q; Chen L; Chen J
Mol Cell Biol; 2019 Feb; 39(4):. PubMed ID: 30455251
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of MDM2 by hsp90 contributes to mutant p53 stabilization.
Peng Y; Chen L; Li C; Lu W; Chen J
J Biol Chem; 2001 Nov; 276(44):40583-90. PubMed ID: 11507088
[TBL] [Abstract][Full Text] [Related]
8. Phosphomimetic mutation of the N-terminal lid of MDM2 enhances the polyubiquitination of p53 through stimulation of E2-ubiquitin thioester hydrolysis.
Fraser JA; Worrall EG; Lin Y; Landre V; Pettersson S; Blackburn E; Walkinshaw M; Muller P; Vojtesek B; Ball K; Hupp TR
J Mol Biol; 2015 Apr; 427(8):1728-47. PubMed ID: 25543083
[TBL] [Abstract][Full Text] [Related]
9. Hsp90 chaperones wild-type p53 tumor suppressor protein.
Walerych D; Kudla G; Gutkowska M; Wawrzynow B; Muller L; King FW; Helwak A; Boros J; Zylicz A; Zylicz M
J Biol Chem; 2004 Nov; 279(47):48836-45. PubMed ID: 15358769
[TBL] [Abstract][Full Text] [Related]
10. Mdmx enhances p53 ubiquitination by altering the substrate preference of the Mdm2 ubiquitin ligase.
Okamoto K; Taya Y; Nakagama H
FEBS Lett; 2009 Sep; 583(17):2710-4. PubMed ID: 19619542
[TBL] [Abstract][Full Text] [Related]
11. TAp73 alpha increases p53 tumor suppressor activity in thyroid cancer cells via the inhibition of Mdm2-mediated degradation.
Malaguarnera R; Vella V; Pandini G; Sanfilippo M; Pezzino V; Vigneri R; Frasca F
Mol Cancer Res; 2008 Jan; 6(1):64-77. PubMed ID: 18234963
[TBL] [Abstract][Full Text] [Related]
12. The chaperone-associated ubiquitin ligase CHIP is able to target p53 for proteasomal degradation.
Esser C; Scheffner M; Höhfeld J
J Biol Chem; 2005 Jul; 280(29):27443-8. PubMed ID: 15911628
[TBL] [Abstract][Full Text] [Related]
13. Hsp90 inhibition has opposing effects on wild-type and mutant p53 and induces p21 expression and cytotoxicity irrespective of p53/ATM status in chronic lymphocytic leukaemia cells.
Lin K; Rockliffe N; Johnson GG; Sherrington PD; Pettitt AR
Oncogene; 2008 Apr; 27(17):2445-55. PubMed ID: 17982489
[TBL] [Abstract][Full Text] [Related]
14. P53 mRNA controls p53 activity by managing Mdm2 functions.
Candeias MM; Malbert-Colas L; Powell DJ; Daskalogianni C; Maslon MM; Naski N; Bourougaa K; Calvo F; Fåhraeus R
Nat Cell Biol; 2008 Sep; 10(9):1098-105. PubMed ID: 19160491
[TBL] [Abstract][Full Text] [Related]
15. Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.
Lindström MS; Jin A; Deisenroth C; White Wolf G; Zhang Y
Mol Cell Biol; 2007 Feb; 27(3):1056-68. PubMed ID: 17116689
[TBL] [Abstract][Full Text] [Related]
16. Acetylation-dependent regulation of MDM2 E3 ligase activity dictates its oncogenic function.
Nihira NT; Ogura K; Shimizu K; North BJ; Zhang J; Gao D; Inuzuka H; Wei W
Sci Signal; 2017 Feb; 10(466):. PubMed ID: 28196907
[TBL] [Abstract][Full Text] [Related]
17. MDM2 Inhibits Axin-Induced p53 Activation Independently of its E3 Ligase Activity.
He Y; Lian G; Lin S; Ye Z; Li Q
PLoS One; 2013; 8(6):e67529. PubMed ID: 23826318
[TBL] [Abstract][Full Text] [Related]
18. Co-chaperones Bag-1, Hop and Hsp40 regulate Hsc70 and Hsp90 interactions with wild-type or mutant p53.
King FW; Wawrzynow A; Höhfeld J; Zylicz M
EMBO J; 2001 Nov; 20(22):6297-305. PubMed ID: 11707401
[TBL] [Abstract][Full Text] [Related]
19. The Wip1 Phosphatase acts as a gatekeeper in the p53-Mdm2 autoregulatory loop.
Lu X; Ma O; Nguyen TA; Jones SN; Oren M; Donehower LA
Cancer Cell; 2007 Oct; 12(4):342-54. PubMed ID: 17936559
[TBL] [Abstract][Full Text] [Related]
20. Ret finger protein 2 enhances ionizing radiation-induced apoptosis via degradation of AKT and MDM2.
Joo HM; Kim JY; Jeong JB; Seong KM; Nam SY; Yang KH; Kim CS; Kim HS; Jeong M; An S; Jin YW
Eur J Cell Biol; 2011 May; 90(5):420-31. PubMed ID: 21333377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]